US Broker Ratings

BGM Group Ltd. (BGM): Investor Outlook on a Healthcare Stock with a 52-Week Range Highlighting High Volatility

BGM Group Ltd. (BGM), a Chinese company in the healthcare sector, specializes in manufacturing and distributing active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products. Despite its..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Navigating a 147% Potential Upside in the Biotech Arena

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a prominent player in the healthcare sector, particularly in the niche of drug manufacturing for specialty and generic medications, has captured investor attention with its..

Omnicell, Inc. (OMCL) Investor Outlook: 44% Potential Upside Beckons Savvy Investors

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare technology sector, offers a compelling opportunity for investors seeking exposure to innovative health information services. Despite current market volatility, Omnicell’s..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 218% Upside Opportunity

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical company specializing in treatments for severe allergic reactions, is currently on the radar of individual investors looking for high-upside opportunities in the biotechnology..

Certara, Inc. (CERT) Stock Analysis: Exploring a 36% Potential Upside for Investors

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, particularly within the health information services industry, is capturing investor attention with a notable 36.42% potential upside. With a..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 29% Potential Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents a compelling case. This Houston-based company operates outpatient physical therapy clinics and offers industrial injury..

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a 58% Upside Potential

For investors with an eye on the healthcare sector, Integra LifeSciences Holdings Corporation (NASDAQ: IART) offers intriguing prospects. Despite current challenges, the potential upside of 58.05% indicated by analysts positions..

Dyne Therapeutics, Inc. (DYN) Investor Outlook: Exploring a Potential 115% Upside in Biotech

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to developing therapeutics for neuromuscular diseases. Headquartered in Waltham, Massachusetts,..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 42.5% Potential Upside in the Medical Devices Sector

Artivion, Inc. (NYSE: AORT), a prominent player in the medical devices industry, has been garnering attention from investors due to its robust growth potential and strategic positioning within the healthcare..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A Biotech Gem with 40.86% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has recently captured the attention of investors with its promising pipeline in the healthcare sector, specializing in biotechnology. With a market cap of $3.03 billion,..

Teladoc Health, Inc. (TDOC) Investor Outlook: Assessing the 34.82% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) stands at a fascinating juncture in the healthcare industry as it continues to solidify its position in the burgeoning field of virtual healthcare services. With..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 65% Upside Potential in the Healthcare Sector

For investors seeking opportunities within the healthcare sector, Perrigo Company plc (NYSE: PRGO) offers a compelling case. With its current stock price at $10.29 and a potential upside of 65.21%..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals 40.39% Potential Upside Amid Robust Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has emerged as a notable player in the biotechnology sector, specializing in the development and commercialization of innovative therapies for rare and orphan diseases. With..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring Its 6.14% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD) operates within the healthcare sector, specifically focusing on medical care facilities across the United States. With a market capitalization of $1.73 billion, the company..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring 30.40% Potential Upside in Non-Opioid Innovation

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of non-opioid pain management solutions, offering investors a unique proposition in the healthcare sector, specifically within the drug manufacturing industry. With..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: Exploring a 40% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is a burgeoning player in the biotechnology sector, specifically focusing on innovative treatments for muscle disorders. With a market capitalization of $3.07 billion, this Boulder,..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unveiling a 47.87% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling opportunity for investors keen on the burgeoning biopharmaceutical sector. With a market capitalization of $1.68 billion, this Minnesota-headquartered company has carved out..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Unpacking a 62.81% Potential Upside in the Thriving Cell & Gene Therapy Market

BioLife Solutions, Inc. (NASDAQ: BLFS) has captured the attention of investors with its robust position in the rapidly expanding cell and gene therapy (CGT) market. Based in Bothell, Washington, this..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Navigating the Vaccine Market with a 3.23% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is a commercial-stage biopharmaceutical company that has carved a niche within the healthcare sector, specifically in the specialty and generic drug manufacturing industry. With a..

Guardian Pharmacy Services, Inc (GRDN): Investor Outlook Reveals an 8.23% Upside Potential

Guardian Pharmacy Services, Inc (GRDN) is making waves in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Atlanta, Georgia, this company specializes in delivering pharmacy services..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds